INIS
viruses
100%
g-proteins
100%
benzimidazoles
100%
humans
75%
in vitro
25%
children
25%
risks
25%
therapy
25%
mortality
25%
patients
12%
in vivo
12%
screening
12%
drugs
12%
rats
12%
testing
12%
surfaces
12%
vaccines
12%
morbidity
12%
mutations
12%
length
12%
pediatrics
12%
infants
12%
hydrogen 1
12%
pneumonia
12%
heparin
12%
prophylaxis
12%
cotton
12%
lead compounds
12%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Protein Function
100%
Cells
28%
Mortality
28%
Experiment
28%
Viral Replication
28%
Age
28%
Time
14%
Vaccine Efficacy
14%
Cell Surface
14%
Morbidity
14%
Virus
14%
Length
14%
Viral Disease
14%
Antiviral Activity
14%
Paramyxoviridae
14%
Respiratory Syncytial Virus Infection
14%
Bronchiolitis
14%
Rat Model
14%
Viral Load
14%
High Risk Population
14%
Cotton Rat
14%
EC50
14%
High Throughput Screening
14%
Pharmacology, Toxicology and Pharmaceutical Science
Keyphrases
Virus-to-cell
16%
1H-benzimidazole
16%
Furyl
16%
Chemical Analogs
16%
Thiadiazol
16%